Navigation Links
PROLOR Biotech Announces Initiation of Phase I Clinical Trial for its Long-Acting Growth Hormone
Date:9/21/2009

NES-ZIONA, Israel, Sept. 21 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. (OTC Bulletin Board: PBTH) formerly Modigene Inc., today announced the initiation of a Phase I clinical trial of its long-acting human growth hormone drug candidate hGH-CTP.

hGH-CTP is being developed to provide growth hormone deficient adults and children with the option to replace the multiple injections per week that are currently required with a once-weekly or bi-monthly injection. The initiation of the trial follows a successful safety and immunogenicity study of hGH-CTP in primates and regulatory approvals by the IRB committee of the Tel-Aviv Medical Center and the Israeli Ministry of Health.

The Phase I trial is a randomized, double-blinded, placebo-controlled, single-dose, dose-escalating study to evaluate the safety, tolerability, and pharmacokinetic and pharmacodynamic properties of hGH-CTP in 24 healthy volunteers. It will be conducted at the Early-Phase Clinical Pharmacology Unit located at the Tel-Aviv Medical Center.

"The initiation of a Phase I clinical trial of our long-acting hGH-CTP represents an important milestone for PROLOR," said Dr. Avri Havron, CEO of PROLOR. "We were delighted with the results of our hGH-CTP studies in primates, which showed that hGH-CTP had an excellent half-life and biological activity and was safe at all doses tested without any signs of immunogenicity. We are now eager to obtain data on its bioactivity in humans."

Dr. Havron continued, "This trial is being conducted at the Early-Phase Clinical Pharmacology Unit at the Tel-Aviv Sourasky Medical Center, a top-notch facility that has a successful track record of conducting more than 250 clinical studies for leading global pharmaceutical and biotech companies in a variety of clinical areas. We look forward to completing the Phase I trial so that we can move ahead with the further clinical develo
'/>"/>

SOURCE PROLOR Biotech, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
2. PROLOR Biotech Announces $10 Million Preferred Stock Line From Members of The Frost Group
3. PROLOR Biotech Acquires License Option from Yeda for Development of Long-Acting Anti-Obesity Drug
4. PROLOR Biotech to Present at the UBS 2009 Global Life Sciences Conference
5. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
6. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
7. ISI Increases West Coast Life Science and Biotech Support for Emerging Companies with Expansion in San Francisco and San Diego
8. Amyris Biotechnologies Co-Founder Neil Renninger Named to Technology Reviews Prestigious TR35 List of Top Young Innovators
9. Finkelstein Thompson LLP Announces GPC Biotech AG Investigation
10. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
11. Clinical Data Acquires Epidauros Biotechnologie AG, Significantly Enhancing Proprietary Genetic Biomarker Portfolio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...SAN DIEGO, Dec. 1 Aethlo...ed today that it will present at the LD MICRO Conf...(PST) at the Luxe Hotel in Los Angeles. Aethlon Me...sent a corporate overview and will provide an upda... product, the Hemopurifier®, a first-in-class...
(Date:12/1/2009)...OLIS and NORTH VANCOUVER, British Columbia, Dec. 1... wholly owned subsidiary of The Dow Chemical Compa...today announced the signing of a research and comm...vides Dow AgroSciences with access to Agrisoma,s p...on an exclusive basis in major food crops, and on ...
(Date:12/1/2009)...CISCO, Dec. 1 Medizone I...unced today that in tests involving its proprietar...k "6 log" decontamination barriers, this time with...ridium difficile and Bacillis subtilis. These resu...ely potent sporicidal technology. "The implication...
(Date:12/1/2009)..., Dec. 1 GeoVax Labs, I...n Atlanta-based, biopharmaceutical company develop...uman Immunodeficiency Virus) and other infectious ... Day. ,, "Today is the 21st World AIDS Day and ...ight with the HIV/AIDS pandemic, we remain focused...
Breaking Biology Technology:Aethlon Medical to Present at LD MICRO Conference on December 3, 2009 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 2Dow AgroSciences, Agrisoma Biosciences Announce Research and Commercial License Option Agreement for Agricultural Crops 3Medizone International Takes Aim at the Bioterrorism Countermeasures Arena 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 2GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 3GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 4GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 5GeoVax Labs, Inc. Celebrates 21st World AIDS Day With Continued Clinical Trial Progress 6
... China, BEIJING, Nov. 12 /Xinhua-PRNewswire-First...mpany") (Nasdaq: CMED ), a leading China-based,me...nd markets advanced in-,vitro diagnostic products,...l for its Breast Cancer HER-2 FISH probe (the "HER...istration ("SFDA") in China., The HER-2 FISH prob...
... "Horror In The Wind," has been banned b...reports that Allen Theaters refused to screen the ...l. "Horror In The Wind" is about two bi... world,s sexual orientation. , ...Made for under $53,000, sci fi comedy " Horro...
...group in Trinity,Biotech plc (Nasdaq: TRIB ), an ...ic products whose shares are traded in the form of...has initiated a campaign for,conversion of company...meeting of shareholders to consider a change in th...l by Trinity Biotech directors,to honor an earlier...
Other Biology Technology:China Medical Technologies Receives SFDA Approval for Breast Cancer HER-2 FISH Probe 2Comedy 'Horror In The Wind' Banned In New Mexico 2Comedy 'Horror In The Wind' Banned In New Mexico 3
(Date:12/2/2009)...HAM, N.C. Duke University Medical Center research...nt brain cancer glioma may be better able to resis...articular signaling pathway in these cancer stem c...s with radiation in a laboratory experiment. , ...that cancer stem cells resist the effects of radia...
(Date:12/2/2009)...cientists are reporting the first identification o...formation that changes harmless marine bacteria in...dy appears in ACS, Environmental Science & Techno... colleagues note that bleaching already has destro...nd scientists are searching for ways to slow or st...
(Date:12/2/2009)... York, NY, December 2, 2009 Commonly prescribed b...f asthma in pregnant women as well as pre-term lab...isorders, psychiatric pathology, cognitive problem...ccording to a new study published in the December ...& Gynecology . , Beta 2 adrenergic agonist drugs...
Breaking Biology News(10 mins):Discovery makes brain tumor cells more responsive to radiation 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Mathematics taking guesswork out of plastic surgery tissue transfer 51659 1Mathematics taking guesswork out of plastic surgery tissue transfer 51659 2Mathematics taking guesswork out of plastic surgery tissue transfer 51659 3Mathematics taking guesswork out of plastic surgery tissue transfer 51659 4Journal of Vascular and Interventional Radiology increases impact international reach 9261 1Journal of Vascular and Interventional Radiology increases impact international reach 9261 2Journal of Vascular and Interventional Radiology increases impact international reach 9261 3 2429 4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation 9257 1 2429 4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation 9257 2 2429 4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation 9257 3 2429 4 million grant establishes CTSI at NYU in partnership with Health and Hospitals Corporation 9257 4
... devastating effect on some of the world,s finest ...first report to show the long-term impact of sea t.... , Large sections of coral reefs and much of the...d, say the international team of researchers, who ... coral reefs in the inner islands of the Seychelle...
...logy at the University at Buffalo has received a $...lth to investigate the potential of bone marrow-de...malfunction known as hibernating myocardium. , Hib...cells that have experienced reduced blood flow ove...ary arteries adapt to this deprivation by down-reg...
...e meerkats subject their subordinates to escalatin...o become overly stressed and as a result infertile...hat during the latter half of her pregnancy, the d...her subordinate females from the group for an aver...inates, typically those with whom reproductive con...
Other Biology News:Global warming may have damaged coral reefs forever 2Adult stem cell research at UB targets damaged hearts 2Dominant meerkats render rivals infertile 2
Sheep Growth Hormone from Cell Sciences
Essential Techniques: Antibody Production from Promega
ELF® 97 Immunohistochemistry Kit from Molecular Probes (Invitrogen)
Dynabeads Epithelial Enrich from Dynal Biotech
Biology Products: